| UniProt ID | ATLA3_HUMAN | |
|---|---|---|
| UniProt AC | Q6DD88 | |
| Protein Name | Atlastin-3 | |
| Gene Name | ATL3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 541 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Localizes to endoplasmic reticulum tubules and accumulates in punctuate structures corresponding to 3-way junctions, which represent crossing-points at which the tubules build a polygonal |
|
| Protein Description | GTPase tethering membranes through formation of trans-homooligomers and mediating homotypic fusion of endoplasmic reticulum membranes. Functions in endoplasmic reticulum tubular network biogenesis. [PubMed: 18270207] | |
| Protein Sequence | MLSPQRVAAAASRGADDAMESSKPGPVQVVLVQKDQHSFELDEKALASILLQDHIRDLDVVVVSVAGAFRKGKSFILDFMLRYLYSQKESGHSNWLGDPEEPLTGFSWRGGSDPETTGIQIWSEVFTVEKPGGKKVAVVLMDTQGAFDSQSTVKDCATIFALSTMTSSVQIYNLSQNIQEDDLQQLQLFTEYGRLAMDEIFQKPFQTLMFLVRDWSFPYEYSYGLQGGMAFLDKRLQVKEHQHEEIQNVRNHIHSCFSDVTCFLLPHPGLQVATSPDFDGKLKDIAGEFKEQLQALIPYVLNPSKLMEKEINGSKVTCRGLLEYFKAYIKIYQGEDLPHPKSMLQATAEANNLAAAASAKDIYYNNMEEVCGGEKPYLSPDILEEKHCEFKQLALDHFKKTKKMGGKDFSFRYQQELEEEIKELYENFCKHNGSKNVFSTFRTPAVLFTGIVALYIASGLTGFIGLEVVAQLFNCMVGLLLIALLTWGYIRYSGQYRELGGAIDFGAAYVLEQASSHIGNSTQATVRDAVVGRPSMDKKAQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MLSPQRVAAA -----CCCHHHHHHH | 20.07 | 25159151 | |
| 12 | Phosphorylation | QRVAAAASRGADDAM HHHHHHHHCCHHHHH | 26.90 | 22199227 | |
| 19 | Sulfoxidation | SRGADDAMESSKPGP HCCHHHHHHHCCCCC | 7.07 | 21406390 | |
| 21 | Phosphorylation | GADDAMESSKPGPVQ CHHHHHHHCCCCCEE | 30.49 | 18491316 | |
| 22 | Phosphorylation | ADDAMESSKPGPVQV HHHHHHHCCCCCEEE | 29.57 | 18491316 | |
| 23 (in isoform 1) | Ubiquitination | - | 64.37 | 21890473 | |
| 23 | Ubiquitination | DDAMESSKPGPVQVV HHHHHHCCCCCEEEE | 64.37 | 21906983 | |
| 34 | 2-Hydroxyisobutyrylation | VQVVLVQKDQHSFEL EEEEEEECCCCCEEC | 52.45 | - | |
| 38 | Phosphorylation | LVQKDQHSFELDEKA EEECCCCCEECCHHH | 18.12 | 25159151 | |
| 85 | Phosphorylation | DFMLRYLYSQKESGH HHHHHHHHHCCCCCC | 10.50 | - | |
| 93 | Phosphorylation | SQKESGHSNWLGDPE HCCCCCCCCCCCCCC | 32.97 | - | |
| 130 | Ubiquitination | SEVFTVEKPGGKKVA EEEEEEECCCCCEEE | 44.63 | - | |
| 239 (in isoform 1) | Ubiquitination | - | 36.20 | 21890473 | |
| 239 | Malonylation | LDKRLQVKEHQHEEI HHHCCCCCHHCHHHH | 36.20 | 26320211 | |
| 239 | Methylation | LDKRLQVKEHQHEEI HHHCCCCCHHCHHHH | 36.20 | - | |
| 239 | 2-Hydroxyisobutyrylation | LDKRLQVKEHQHEEI HHHCCCCCHHCHHHH | 36.20 | - | |
| 239 | Ubiquitination | LDKRLQVKEHQHEEI HHHCCCCCHHCHHHH | 36.20 | 21906983 | |
| 261 | Phosphorylation | HSCFSDVTCFLLPHP HHHHCCCCEEECCCC | 11.52 | - | |
| 283 | 2-Hydroxyisobutyrylation | PDFDGKLKDIAGEFK CCCCCCHHHHHHHHH | 51.04 | - | |
| 283 (in isoform 1) | Ubiquitination | - | 51.04 | 21890473 | |
| 283 | Malonylation | PDFDGKLKDIAGEFK CCCCCCHHHHHHHHH | 51.04 | 32601280 | |
| 283 | Ubiquitination | PDFDGKLKDIAGEFK CCCCCCHHHHHHHHH | 51.04 | 21906983 | |
| 309 | 2-Hydroxyisobutyrylation | NPSKLMEKEINGSKV CHHHHCHHHHCCCCC | 50.34 | - | |
| 309 | Ubiquitination | NPSKLMEKEINGSKV CHHHHCHHHHCCCCC | 50.34 | - | |
| 315 | Ubiquitination | EKEINGSKVTCRGLL HHHHCCCCCCHHHHH | 42.85 | - | |
| 317 | Phosphorylation | EINGSKVTCRGLLEY HHCCCCCCHHHHHHH | 10.54 | 28270605 | |
| 324 | Phosphorylation | TCRGLLEYFKAYIKI CHHHHHHHHHHHHHH | 15.45 | 28270605 | |
| 326 | Ubiquitination | RGLLEYFKAYIKIYQ HHHHHHHHHHHHHHC | 39.10 | - | |
| 328 | Phosphorylation | LLEYFKAYIKIYQGE HHHHHHHHHHHHCCC | 11.88 | 28270605 | |
| 330 | Ubiquitination | EYFKAYIKIYQGEDL HHHHHHHHHHCCCCC | 23.76 | - | |
| 341 | Ubiquitination | GEDLPHPKSMLQATA CCCCCCCHHHHHHHH | 45.52 | 21906983 | |
| 341 (in isoform 1) | Ubiquitination | - | 45.52 | 21890473 | |
| 342 | Phosphorylation | EDLPHPKSMLQATAE CCCCCCHHHHHHHHH | 29.22 | 20068231 | |
| 343 | Sulfoxidation | DLPHPKSMLQATAEA CCCCCHHHHHHHHHH | 3.92 | 21406390 | |
| 347 | Phosphorylation | PKSMLQATAEANNLA CHHHHHHHHHHHHHH | 16.45 | 20068231 | |
| 358 | Phosphorylation | NNLAAAASAKDIYYN HHHHHHHHHHHHHHC | 30.99 | 30622161 | |
| 360 | Ubiquitination | LAAAASAKDIYYNNM HHHHHHHHHHHHCCH | 42.01 | - | |
| 375 | Acetylation | EEVCGGEKPYLSPDI HHHHCCCCCCCCHHH | 42.09 | 26051181 | |
| 379 | Phosphorylation | GGEKPYLSPDILEEK CCCCCCCCHHHHHHH | 18.06 | 25159151 | |
| 386 | Ubiquitination | SPDILEEKHCEFKQL CHHHHHHHCCHHHHH | 44.15 | - | |
| 386 | 2-Hydroxyisobutyrylation | SPDILEEKHCEFKQL CHHHHHHHCCHHHHH | 44.15 | - | |
| 391 (in isoform 1) | Ubiquitination | - | 23.31 | 21890473 | |
| 391 | Acetylation | EEKHCEFKQLALDHF HHHCCHHHHHHHHHH | 23.31 | 19608861 | |
| 391 | Ubiquitination | EEKHCEFKQLALDHF HHHCCHHHHHHHHHH | 23.31 | 2189047 | |
| 399 | 2-Hydroxyisobutyrylation | QLALDHFKKTKKMGG HHHHHHHHHHHHCCC | 56.99 | - | |
| 399 | Acetylation | QLALDHFKKTKKMGG HHHHHHHHHHHHCCC | 56.99 | 25953088 | |
| 400 | Acetylation | LALDHFKKTKKMGGK HHHHHHHHHHHCCCC | 65.71 | 19822203 | |
| 402 | Acetylation | LDHFKKTKKMGGKDF HHHHHHHHHCCCCCC | 50.03 | 19822211 | |
| 407 | Ubiquitination | KTKKMGGKDFSFRYQ HHHHCCCCCCCHHHH | 50.28 | - | |
| 407 | Malonylation | KTKKMGGKDFSFRYQ HHHHCCCCCCCHHHH | 50.28 | 26320211 | |
| 410 | Phosphorylation | KMGGKDFSFRYQQEL HCCCCCCCHHHHHHH | 20.96 | 24719451 | |
| 430 | Ubiquitination | ELYENFCKHNGSKNV HHHHHHHHHCCCCCH | 35.65 | - | |
| 515 | Phosphorylation | AYVLEQASSHIGNST HHHHHHHHHHCCCCC | 23.34 | 30576142 | |
| 522 | Phosphorylation | SSHIGNSTQATVRDA HHHCCCCCCCHHHHH | 26.65 | 30576142 | |
| 525 | Phosphorylation | IGNSTQATVRDAVVG CCCCCCCHHHHHHCC | 13.27 | 30576142 | |
| 535 | Phosphorylation | DAVVGRPSMDKKAQ- HHHCCCCCCCCCCC- | 37.95 | 23401153 | |
| 536 | Sulfoxidation | AVVGRPSMDKKAQ-- HHCCCCCCCCCCC-- | 10.97 | 30846556 | |
| 538 | Ubiquitination | VGRPSMDKKAQ---- CCCCCCCCCCC---- | 41.17 | - | |
| 539 | Ubiquitination | GRPSMDKKAQ----- CCCCCCCCCC----- | 47.99 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATLA3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATLA3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATLA3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615632 | Neuropathy, hereditary sensory, 1F (HSN1F) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-391, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND MASSSPECTROMETRY. | |